ResearcherShanghai Jiao Tong UniversityActive in the last 2 years
Yuzo Kodama
Matched on ORCID iD 0000-0002-1741-5638; OpenAlex author ID A5101805418. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 40
2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers
Papers 7
- Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nationwide clinical database. Co-author DOI 10.1007/s00535-026-02480-8↗
- Long-term outcomes of plastic versus metal stents for preoperative biliary drainage in pancreatic cancer: a nationwide propensity score-matched analysis. Co-author DOI 10.1016/j.gie.2026.05.032↗
- Impaired Consciousness Due to Hyperammonemia During S-1 Administration for Unresectable Pancreatic Cancer. Last author DOI 10.2169/internalmedicine.3771-24↗
- A Prospective Multicenter Study of Partially Covered Metal Stents in Patients Receiving Neoadjuvant Chemotherapy for Resectable and Borderline Resectable Pancr… Co-author DOI 10.5009/gnl19302↗
- Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer. Co-author DOI 10.18632/oncotarget.24865↗
- Validation of Lymphocyte-to-Monocyte Ratio as a Prognostic Factor in Advanced Pancreatic Cancer: An East Asian Cohort Study of 2 Countries. Co-author DOI 10.1097/mpa.0000000000000891↗
- Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally advanced pancreatic cancer. Co-author DOI 10.1016/j.pan.2015.09.016↗
Closest collaborators
The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shin Hamada · 2 shared papers, 2026 · strength 0.48
- Paper Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nation… DOI 10.1007/s00535-026-02480-8↗
- Paper Long-term outcomes of plastic versus metal stents for preoperative biliary drainage in pancreatic cancer: a nationwide … DOI 10.1016/j.gie.2026.05.032↗
- Sohei Satoi · 2 shared papers, 2026 · strength 0.48
- Paper Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nation… DOI 10.1007/s00535-026-02480-8↗
- Paper Long-term outcomes of plastic versus metal stents for preoperative biliary drainage in pancreatic cancer: a nationwide … DOI 10.1016/j.gie.2026.05.032↗
- Shinichi Egawa · 2 shared papers, 2026 · strength 0.48
- Paper Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nation… DOI 10.1007/s00535-026-02480-8↗
- Paper Long-term outcomes of plastic versus metal stents for preoperative biliary drainage in pancreatic cancer: a nationwide … DOI 10.1016/j.gie.2026.05.032↗
- Kohei Nakata · 2 shared papers, 2026 · strength 0.48
- Paper Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nation… DOI 10.1007/s00535-026-02480-8↗
- Paper Long-term outcomes of plastic versus metal stents for preoperative biliary drainage in pancreatic cancer: a nationwide … DOI 10.1016/j.gie.2026.05.032↗
- Masamichi Mizuma · 2 shared papers, 2026 · strength 0.48
- Paper Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nation… DOI 10.1007/s00535-026-02480-8↗
- Paper Long-term outcomes of plastic versus metal stents for preoperative biliary drainage in pancreatic cancer: a nationwide … DOI 10.1016/j.gie.2026.05.032↗
- Ichiro Yasuda · 2 shared papers, 2026 · strength 0.48
- Paper Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nation… DOI 10.1007/s00535-026-02480-8↗
- Paper Long-term outcomes of plastic versus metal stents for preoperative biliary drainage in pancreatic cancer: a nationwide … DOI 10.1016/j.gie.2026.05.032↗
- Yoshifumi Takeyama · 2 shared papers, 2026 · strength 0.48
- Paper Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nation… DOI 10.1007/s00535-026-02480-8↗
- Paper Long-term outcomes of plastic versus metal stents for preoperative biliary drainage in pancreatic cancer: a nationwide … DOI 10.1016/j.gie.2026.05.032↗
- Michiaki Unno · 2 shared papers, 2026 · strength 0.48
- Paper Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nation… DOI 10.1007/s00535-026-02480-8↗
- Paper Long-term outcomes of plastic versus metal stents for preoperative biliary drainage in pancreatic cancer: a nationwide … DOI 10.1016/j.gie.2026.05.032↗
- Atsushi Masamune · 2 shared papers, 2026 · strength 0.48
- Paper Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nation… DOI 10.1007/s00535-026-02480-8↗
- Paper Long-term outcomes of plastic versus metal stents for preoperative biliary drainage in pancreatic cancer: a nationwide … DOI 10.1016/j.gie.2026.05.032↗
- Takao Itoi · 2 shared papers, 2026 · strength 0.48
- Paper Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nation… DOI 10.1007/s00535-026-02480-8↗
- Paper Long-term outcomes of plastic versus metal stents for preoperative biliary drainage in pancreatic cancer: a nationwide … DOI 10.1016/j.gie.2026.05.032↗
- Ken Shirabe · 2 shared papers, 2026 · strength 0.48
- Paper Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nation… DOI 10.1007/s00535-026-02480-8↗
- Paper Long-term outcomes of plastic versus metal stents for preoperative biliary drainage in pancreatic cancer: a nationwide … DOI 10.1016/j.gie.2026.05.032↗
- Nagahiro Tokuyama · 1 shared paper, 2025 · strength 0.30
- So Yamaki · 1 shared paper, 2026 · strength 0.24
- Daisuke Hashimoto · 1 shared paper, 2026 · strength 0.24
- Kazumasa Nagai · 1 shared paper, 2026 · strength 0.24
- Manabu Kawai · 1 shared paper, 2026 · strength 0.24
- Kazuichi Okazaki · 1 shared paper, 2026 · strength 0.24
- Masashi Kanai · 3 shared papers, 2015–2018 · strength 0.18
- Paper Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer. DOI 10.18632/oncotarget.24865↗
- Paper Validation of Lymphocyte-to-Monocyte Ratio as a Prognostic Factor in Advanced Pancreatic Cancer: An East Asian Cohort S… DOI 10.1097/mpa.0000000000000891↗
- Paper Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally adva… DOI 10.1016/j.pan.2015.09.016↗
- Kyoichi Takaori · 3 shared papers, 2015–2018 · strength 0.18
- Paper Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer. DOI 10.18632/oncotarget.24865↗
- Paper Validation of Lymphocyte-to-Monocyte Ratio as a Prognostic Factor in Advanced Pancreatic Cancer: An East Asian Cohort S… DOI 10.1097/mpa.0000000000000891↗
- Paper Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally adva… DOI 10.1016/j.pan.2015.09.016↗
- Atsushi Kanno · 1 shared paper, 2021 · strength 0.13
- Masahiro Itonaga · 1 shared paper, 2021 · strength 0.13
- Hiroyuki Isayama · 1 shared paper, 2021 · strength 0.13
- Kazumichi Kawakubo · 1 shared paper, 2021 · strength 0.13
- Kei Saito · 1 shared paper, 2021 · strength 0.13
- Akio Katanuma · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.